Statistics
Publications
1
Citations
35
H-Index
1
Active since
2019
Affiliations
James Ge is an author at Karyopharm Therapeutics (United States) specializing in tyrosine kinase inhibitor therapy, lenvatinib therapy, and tumor progression.
Publications per year
2019–2019
1
1
1–1 of 1